Sai Sridhar Pharma Private Limited, a active private limited company, was established on 12 October 2007 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2007PTC055902. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.25 M and a paid-up capital of ₹0.24 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Udaya Lakshmi Tadepalli (Additional Director), Phani Srinivas Ramella (Director), Paidiwar Srinivas (Director). Past directors included Phani Srinivas Ramella, Dundigalla Chandrasekhar, Paidiwar Srinivas. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No : 5, First Floor, Opp : Idpl Company Balanagar, Hyderabad, Telangana, 500037.
U24232TG2007PTC055902
055902
12 October 2007
₹0.25 M
₹0.24 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sai Sridhar Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Udaya Lakshmi Tadepalli | Additional Director | 23 May 2023 | Current |
| Phani Srinivas Ramella | Director | 15 Mar 2010 | Current |
| Paidiwar Srinivas | Director | 16 Oct 2017 | Current |
| Satya Murali Krishna Kammila | Director | 29 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Sep 2010 | Past |
| Pramod Abcsdd | Director | 15 Mar 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 16 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sai Sridhar Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.59% increase. The company also saw a substantial improvement in profitability, with a 32.43% increase in profit. The company's net worth Soared by an impressive increase of 28.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sai Sridhar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sai Sridhar Pharma has a workforce of 21 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sai Sridhar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Sridhar Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sai Sridhar Pharma Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was completed.
Progress on Sai Sridhar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
The activity Udaya Lakshmi Tadepalli was appointed as a Additional Director was appointed as a Additional Director on 23 May 2023 & has been associated with this company since 2 years 7 months . was completed.
The activity Satya Murali Krishna Kammila was appointed as a Director was appointed as a Director on 29 Sep 2021 & has been associated with this company since 4 years 3 months . was completed.
The activity Paidiwar Srinivas was appointed as a Director was appointed as a Director on 16 Oct 2017 & has been associated with this company since 8 years 2 months . was completed.
Phani Srinivas Ramella was appointed as a Director was appointed as a Director on 15 Mar 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
The CIN of Sai Sridhar Pharma Private Limited is U24232TG2007PTC055902.
Sai Sridhar Pharma Private Limited is headquartered at Plot No : 5, First Floor, Opp : Idpl Company Balanagar, Hyderabad, Telangana, 500037.
Sai Sridhar Pharma Private Limited was incorporated on 12 October 2007.
The current directors of Sai Sridhar Pharma Private Limited are
The primary industry of Sai Sridhar Pharma Private Limited is Trade.
Sai Sridhar Pharma Private Limited is unlisted.
The authorized capital of Sai Sridhar Pharma Private Limited is ₹0.25 M, and the paid-up capital is ₹0.24 M.
The compliance status of Sai Sridhar Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX